Most of the FBLN2 and PDGFD variant carriers have comorbidities typical of adult IPAH patients [64, 65], including hypertension, hypothyroidism, other pulmonary diseases, and metabolic diseases. Here, FBLN2 is linked to idiopathic pulmonary arterial hypertension.